2023 Original Papers / 2023 原著論文
- Maeda, K.; Ohrui, S.; Tokuda, A.; Nagumo, Y.; Yamamoto, N.; Tanimura, R.; Saitoh, T.; Kutsumura, N.; Nagase, H.
“Unexpected Rearrangement Reactions of the 14-Aminonaltrexone Skeleton”
Org. Lett. 2023, 25, 3407-3411. (web) - Lin, Y.; Roy, K.; Ioka, S.; Otani, R.; Amezawa, M.; Ishikawa, Y.; Cherasse, Y.; Kaushik, M. K.; Klewe-Nebenius, D.; Zhou, L.; Yanagisawa, M.; Oishi, Y.; Saitoh, T.; Lazarus, M.
“Positive allosteric adenosine A2A receptor modulation suppresses insomnia associated with mania- and schizophrenia-like behaviors in mice”
Front. Pharmacol. 2023, 14, 1138666. (web) - Iio, K.; Hashimoto, K.; Nagumo, Y.; Amezawa, M.; Hasegawa, T.; Yamamoto, N.; Kutsumura, N.; Takeuchi, K.; Ishikawa, Y.; Yamamoto, H.; Tokuda, A.; Sato, T.; Uchida, Y.; Inoue, A.; Tanimura, R.; Yanagisawa, M.; Nagase, H.; Saitoh, T.
“Design and Synthesis of Orexin 1 Receptor-Selective Agonists”
J. Med. Chem. 2023, 66, 5453-5464. (web) - Amezawa, M.; Yamamoto, N.; Nagumo, Y.; Kutsumura, N.; Ishikawa, Y.; Yanagisawa, M.; Nagase, H.; Saitoh, T.
“Design and synthesis of novel orexin 2 receptor agonists with a 1,3,5-trioxazatriquinane skeleton”
Bioorg. Med. Chem. Lett. 2023, 82, 129151. (web)
